Cargando…

The scientific method: pillar and pitfall of cancer research

Detalles Bibliográficos
Autores principales:	Tu, Shi-Ming, Bilen, Mehmet Asim, Tannir, Nizar M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303171/ https://www.ncbi.nlm.nih.gov/pubmed/24711219 http://dx.doi.org/10.1002/cam4.248

Ejemplares similares

Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody
por: Bilen, Mehmet Asim, et al.
Publicado: (2016)

Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas
por: Alhalabi, Omar, et al.
Publicado: (2023)

Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
por: Tannir, Nizar M, et al.
Publicado: (2022)

Physics with Maurice: a scientific pillar of CERN
por: Ellis, John
Publicado: (2008)

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
por: Thouvenin, Jonathan, et al.
Publicado: (2022)

Scientific integrity at Science Advances: Essential pillar supporting scientific progress
por: Yeagle, Philip
Publicado: (2021)

Benefits and pitfalls of scientific research during undergraduate medical education
por: Kuhnigk, Olaf, et al.
Publicado: (2010)

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors
por: Shabto, Julie M., et al.
Publicado: (2020)

p53 expression in repair/reactive renal tubular cells: A potential pitfall leading to a false‐positive diagnosis of urine cytology
por: Enomoto, Kaori, et al.
Publicado: (2021)

Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma
por: Nazha, Bassel, et al.
Publicado: (2022)

Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
por: Laccetti, Andrew L., et al.
Publicado: (2021)

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Martini, Dylan J., et al.
Publicado: (2019)

Hybridizing five neural-metaheuristic paradigms to predict the pillar stress in bord and pillar method
por: Zhou, Jian, et al.
Publicado: (2023)

The Pillars of the Nose-Crura Shortening for Over Projected Nose
por: Kopacheva-Barsova, Gabriela, et al.
Publicado: (2019)

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Zhuang, Tony Z, et al.
Publicado: (2022)

Pitfalls in applying text mining to scientific literature
por: Neefs, Jean-Marc
Publicado: (2010)

Examining data visualization pitfalls in scientific publications
por: Nguyen, Vinh T, et al.
Publicado: (2021)

Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
por: Siddiqui, Bilal A, et al.
Publicado: (2021)

Ethical and Scientific Pitfalls Concerning Laboratory Research with Non-Human Primates, and Possible Solutions
por: Carvalho, Constança, et al.
Publicado: (2018)

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
por: Rini, Brian I, et al.
Publicado: (2022)

Pillars
por: Jean-Luc Caron
Publicado: (1999)

Pillars.
por: Jean-Luc Caron
Publicado: (1999)

Pillars.
por: Jean-Luc Caron
Publicado: (1999)

The application of crowdsourcing approaches to cancer research: a systematic review
por: Lee, Young Ji, et al.
Publicado: (2017)

Advanced cancer patients’ understanding of prognostic information: Applying insights from psychological research
por: Derry, Heather M., et al.
Publicado: (2019)

Supporting the strategic pillars of translational research in biofilms
por: Camara, Miguel, et al.
Publicado: (2022)

Optimizing methods and dodging pitfalls in microbiome research
por: Kim, Dorothy, et al.
Publicado: (2017)

Clinical and Economic Outcomes in Patients With Metastatic Urothelial Carcinoma Receiving First-Line Systemic Treatment (the IMPACT UC I Study)
por: Bilen, Mehmet A, et al.
Publicado: (2023)

Sarcomatoid hepatocellular carcinoma: From clinical features to cancer genome
por: Zhang, Cheng, et al.
Publicado: (2021)

Phase 2 study of pembrolizumab in patients with advanced rare cancers
por: Naing, Aung, et al.
Publicado: (2020)

How to choose proper local treatment in men aged ≥75 years with cT2 localized prostate cancer?
por: Jin, Kun, et al.
Publicado: (2019)

Scientific publishing in the COVID-19 era: successes and pitfalls
por: Federico, Antonio
Publicado: (2020)

Reuse of Pillaring Agent in Sequential Bentonite Pillaring Processes
por: Bertella, Francine, et al.
Publicado: (2017)

Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study
por: Tannir, Nizar M., et al.
Publicado: (2021)

Diagnostic significance and carcinogenic mechanism of pan‐cancer gene POU5F1 in liver hepatocellular carcinoma
por: He, Dingdong, et al.
Publicado: (2020)

The Pillars of Publication Ethics and Research Integrity: Spread the Word
por: Graf, Chris
Publicado: (2017)

Statistical methods in cancer research /
por: Breslow, Norman E.
Publicado: (1980)

Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial
por: Tey, Jeremy, et al.
Publicado: (2019)

Clinical research associates experience with missing patient reported outcomes data in cancer randomized controlled trials
por: Palmer, Michael J., et al.
Publicado: (2021)

Inflammatory Markers in Cancer Immunotherapy
por: Ravindranathan, Deepak, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_59nu4vbvduqpf7rvd71g1jupif